January 1, 2015Patient Preference and AdherenceOpen Access

Patient values and preferences when choosing anticoagulants

View Full Paper

Ask AI

Bookmark

Population

137 Veterans in primary care clinics and INR laboratory, including 90 not exposed to anticoagulants but at…

Design

Cross-sectional

Authors

LTLeonardo TamarizGeneral / Preventive / Lipids APAna PalacioGeneral / Preventive / Lipids IKIrene KirolosUniversity of Miami

Discussion

Member takes

Implication

Supports individualized shared decision-making for anticoagulants in AF; leaves open whether preferences affect adherence or outcomes.

Structured PICO

Population

137 Veterans in primary care clinics and INR laboratory, including 90 not exposed to anticoagulants but at risk of atrial fibrillation, and 47 exposed to anticoagulants (46 on warfarin, 1 on dabigatran).

Intervention

Survey assessing patient values and preferences regarding anticoagulant attributes based on a hypothetical atrial fibrillation scenario.

Outcome

Patient preference for anticoagulant attributes (efficacy, time on market, antidote availability, quality of life, or physician recommendation).patient reported

Patients at risk for or currently taking anticoagulants for atrial fibrillation strongly prefer to actively participate in shared decision-making and have highly individualized preferences regarding medication attributes such as antidote availability and quality of life.

Cite This Study

Tamariz et al. (2015) studied this question.

synapsesocial.com/papers/6a76381a031c7cb28e008efb https://doi.org/10.2147/ppa.s64295

View Full Paper

Ask AI

Bookmark

Patient values and preferences when choosing anticoagulants

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Patient values and preferences when choosing anticoagulants

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider